ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
EOFY 2025: 3 ASX 200 shares to buy for the year ahead
How to invest
How to create $50k in passive income with ASX shares
How to invest
How to choose your first 5 ASX shares
Growth Shares
The ultimate buy and hold ASX 200 shares for long-term investors
Healthcare Shares
3 leading ASX healthcare shares with global reach
How to invest
How to turn the ASX into a passive income machine
How to invest
How ASX shares can help you retire early
Growth Shares
Top brokers name 3 top ASX growth shares to buy now
Healthcare Shares
Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell?
Blue Chip Shares
3 high-conviction ASX 200 shares I'd buy in June
Broker Notes
Where to invest $10,000 in ASX 200 shares this month
How to invest
How ASX 200 stocks and ASX ETFs can be combined to build the perfect portfolio
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.